Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 228

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Thyroidectomy without Radioiodine in Patients with Low-Risk Thyroid Cancer

Open access
Leboulleux, Sophie, Bournaud, Claire, Chougnet, Cecile N., Zerdoud, Slimane, Al Ghuzlan, Abir, Catargi, Bogdan, Do Cao, Christine, Kelly, Antony, Barge, Marie-Luce, Lacroix, Ludovic, Dygai, Inna, Vera, Pierre, Rusu, Daniela, Schneegans, Olivier, Benisvy, Danielle, Klein, Marc, Roux, Julie, Eberle, Marie-Claude, Bastie, Delphine, Nascimento, Camila, Giraudet, Anne-Laure, Le Moullec, Nathalie, Bardet, Stéphane, Drui, Delphine, Roudaut, Nathalie, Godbert, Yann, Morel, Olivier, Drutel, Anne, Lamartina, Livia, Schvartz, Claire, Velayoudom, Fritz-Line, Schlumberger, Martin-Jean, Leenhardt, Laurence, Borget, Isabelle · 2022 · New England Journal of Medicine

Abstract

BACKGROUND: In patients with low-risk differentiated thyroid cancer undergoing thyroidectomy, the postoperative administration of radioiodine (iodine-131) is controversial in the absence of demonstrated benefits. METHODS: In this prospective, randomized, phase 3 trial, we assigned patients with low-risk differentiated thyroid cancer who were undergoing thyroidectomy to receive ablation with postoperative administration of radioiodine (1.1 GBq) after injections of recombinant human thyrotropin (radioiodine group) or to receive no postoperative radioiodine (no-radioiodine group). The primary objective was to assess whether no radioiodine therapy was noninferior to radioiodine therapy with respect to the absence of a composite end point that included functional, structural, and biologic abnormalities at 3 years. Noninferiority was defined as a between-group difference of less than 5 percentage points in the percentage of patients who did not have events that included the presence of abnormal foci of radioiodine uptake on whole-body scanning that required subsequent treatment (in the radioiodine group only), abnormal findings on neck ultrasonography, or elevated levels of thyroglobulin or thyroglobulin antibodies. Secondary end points included prognostic factors for events and molecular characterization. RESULTS: Among 730 patients who could be evaluated 3 years after randomization, the percentage of patients without an event was 95.6% (95% confidence interval [CI], 93.0 to 97.5) in the no-radioiodine group and 95.9% (95% CI, 93.3 to 97.7) in the radioiodine group, a difference of -0.3 percentage points (two-sided 90% CI, -2.7 to 2.2), a result that met the noninferiority criteria. Events consisted of structural or functional abnormalities in 8 patients and biologic abnormalities in 23 patients with 25 events. Events were more frequent in patients with a postoperative serum thyroglobulin level of more than 1 ng per milliliter during thyroid hormone treatment. Molecular alterations were similar in patients with or without an event. No treatment-related adverse events were reported. CONCLUSIONS: In patients with low-risk thyroid cancer undergoing thyroidectomy, a follow-up strategy that did not involve the use of radioiodine was noninferior to an ablation strategy with radioiodine regarding the occurrence of functional, structural, and biologic events at 3 years. (Funded by the French National Cancer Institute; ESTIMABL2 ClinicalTrials.gov number, NCT01837745.).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa2111953

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 228

Metadata

Authors
Leboulleux, S., Bournaud, C., Chougnet, C. N., Zerdoud, S., Al Ghuzlan, A., Catargi, B., Do Cao, C., Kelly, A., Barge, M.-L., Lacroix, L., Dygai, I., Vera, P., Rusu, D., Schneegans, O., Benisvy, D., Klein, M., Roux, J., Eberle, M.-C., Bastie, D., Nascimento, C., Giraudet, A.-L., Le Moullec, N., Bardet, S., Drui, D., Roudaut, N., Godbert, Y., Morel, O., Drutel, A., Lamartina, L., Schvartz, C., Velayoudom, F.-L., Schlumberger, M.-J., Leenhardt, L., & Borget, I.
Venue
New England Journal of Medicine
Published
2022-03-10
Volume
386
Issue
10
Pages
923-932
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W4220712737
Cited by
228
References
4
FWCI
29.06
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Thyroidectomy without Radioiodine in Patients with Low-Risk Thyroid Cancer. https://app.cochat.ai/papers/10.1056/nejmoa2111953
The paper
Leboulleux, S., Bournaud, C., Chougnet, C. N., Zerdoud, S., Al Ghuzlan, A., Catargi, B., Do Cao, C., Kelly, A., Barge, M.-L., Lacroix, L., Dygai, I., Vera, P., Rusu, D., Schneegans, O., Benisvy, D., Klein, M., Roux, J., Eberle, M.-C., Bastie, D., . . . Borget, I. (2022). Thyroidectomy without Radioiodine in Patients with Low-Risk Thyroid Cancer. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2111953

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.